A new class of drugs that fight migraines could cost as much as $10,000 a year, NBC News reports. » Read More
The death rate from drug overdoses more than doubled between 1999 and 2015, according to a report from the CDC. » Read More
By: Lauren Thomas
Shares of Incyte rose more than 6 percent in Friday trade on news that the pharmaceutical company will join the S&P 500. » Read More
By: Ali Vitali
Vice President Mike Pence issued a proclamation to the Conservative Political Action Conference Thursday: the "Obamacare nightmare is about to end." » Read More
Opposition to the Affordable Care Act has dropped by seven percentage points since early January, before Donald Trump became president.
A Republican push to repeal and replace Obamacare has slowed amid concerns over large numbers of people losing health coverage.
Shkreli is accused of ripping off his former pharma company Retrophin to pay off hedge-fund investors he was accused of defrauding.
Shares of Bristol-Myers climbed as much as 4 percent after billionaire Carl Icahn reportedly took a stake in the company, according to Dow Jones.
Momenta says Pfizer, a key supplier for its multiple sclerosis drug, has received a warning letter from the Food and Drug Administration.
Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers.
UnitedHealth denies allegations it gamed the nation's Medicare system for hundreds of millions of dollars.
The burdens of repealing and replacing Obamacare will fall on consumers, Mark Cuban tells CNBC.
House Speaker Paul Ryan said they plan to introduce legislation as early as next Tuesday.
Spending on health nationally grew by an estimated 4.8 percent in 2016, but is expected to rise at a quicker pace through 2025.
This is occurring even as the Trump administration issues new rules to try to stabilize the Obamacare exchanges.
Tax filers remain responsible for paying a penalty if they fail to have health insurance coverage or an exemption from that mandate.
Researchers used brain scans and an algorithm to improve early diagnosis of autism among several high-risk children.
Open enrollment would run from November through Dec. 15, and states would have control over the size of an insurance plan's network.
Health sensors are popping up in a new place: directly on the skin. Patch start-ups think they will succeed where Fitbit has struggled.
Dermatologists and other specialists are three times more likely than primary care providers to prescribe brand name versions of drugs known as topical immunomodulators.
Get the best of CNBC in your inbox